AVTX - Avalo Therapeutics, Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Avalo Therapeutics, Inc. Common Stock
IPO Date: October 15, 2015
Sector: Healthcare
Industry: Biotech
Market Cap: $888.65M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.37 | 5.62%
Avg Daily Range (30 D): $0.52 | 2.76%
Avg Daily Range (90 D): $0.65 | 3.65%
Institutional Daily Volume
Avg Daily Volume: 4.95M
Avg Daily Volume (30 D): .69M
Avg Daily Volume (90 D): 1.06M
Trade Size
Avg Trade Size (Sh.): 785
Avg Trade Size (Sh.) (30 D): 60
Avg Trade Size (Sh.) (90 D): 74
Institutional Trades
Total Institutional Trades: 431
Avg Institutional Trade: $2.15M
Avg Institutional Trade (30 D): $2.42M
Avg Institutional Trade (90 D): $2.84M
Avg Institutional Trade Volume: .15M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $3.54M
Avg Closing Trade (30 D): $3.13M
Avg Closing Trade (90 D): $3.94M
Avg Closing Volume: 252.78K
 
News
Jun 26, 2026 @ 11:00 AM
Avalo Therapeutics to Join the Russell 2000Ãโ€šÂ® an...
Source: Na
May 6, 2026 @ 3:33 AM
Avalo Therapeutics Announces Pricing of $375 Milli...
Source: Na
Feb 4, 2026 @ 12:00 PM
Avalo Therapeutics to Participate in Upcoming Inve...
Source: Not Specified
Oct 23, 2025 @ 5:00 PM
Hidradenitis Suppurativa Clinical Trial Analysis: ...
Source: Delveinsight
Sep 29, 2025 @ 9:07 AM
Why Merus Shares Are Trading Higher By 38%; Here A...
Source: Avi Kapoor
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $-.83 $-.98 $-.37
Diluted EPS $-.83 $-.98 $-.37
Revenue $M $M $.06M
Gross Profit
Net Income / Loss $-36.36M $-19.63M $-13.72M
Operating Income / Loss $-31.52M $-20.9M $-19.74M
Cost of Revenue
Net Cash Flow $60.3M $9.21M $-11.16M
PE Ratio    
Splits
Dec 29, 2023 1:240
Jul 08, 2022 1:12
Sep 10, 2007 1:51